Five-Year Survival of Cancer Patients Diagnosed 1998-2005

The bars in this graph show the percentage of children with cancer who survived for at least five years after doctors diagnosed their disease. The children represented here were diagnosed between 1998 and 2005, and at that time they were age 30 or younger. The blue bars show the survival rates for Seattle Children's patients; the green bars show the national average survival rates.

5-year survival rate

5-year survival rate 2

Average New Cancer Patients Annually by Disease, 2005-2009

Average new cancer patients

Data sources

  • Seattle Children's Hospital Cancer Registry. Seattle, WA. Analytic diagnoses, Kaplan-Meier Adjusted Model.
  • Commission on Cancer, National Cancer Data Base, Chicago, IL.

Stem Cell Transplant Survival Rates, 2004-2013

The bars in the following graphs show information about Children's patients who had a stem cell transplant. The graph below shows the percentage of patients who survived for at least 100 days after their transplant:

Stem cell transplant (100-day) survival rates, 2004-2013

Stem cell transplant 100-day survival 2013

The graph below shows the percentage of patients who survived for at least one year after their transplant:

Stem cell transplant (1-year) survival rates, 2004-2012

Stem cell transplant 1-year survival 2013

Stem Cell Transplants, 1969-2013

The left side of this graph lists different types of stem cell transplants. The bars show how many of each type were performed for Children's patients between the years of 1969 and 2013. Some of the categories overlap.

Stem cell transplants 2013

  • All the transplants were performed either for non-cancerous diseases or for cancerous diseases. So the total number of transplants in this time period was 448 + 2,243 = 2,691.
  • Each transplant was either myeloablative or non-myeloablative (also known as a "mini-transplant").
  • Each transplant was either autologous (transplanting the patient's own cells) or allogeneic (transplanting cells from a donor). Some allogeneic transplants use a donor related to the patient; some use an unrelated donor. Some of these donors closely match the patient's HLA type; some are mismatched. Some use stem cells that come from cord blood (blood donated from an umbilical cord); some use stem cells taken from bone marrow or peripheral blood (blood that circulates in the body).

Data source